Futura Medical mulling fasttrack European submission for lead drug candidate

Futura Medical mulling fast-track European submission for lead drug candidate

03:49 EDT 24 Jun 2019 | Proactive Investors

Depending on the read-out from current study, it may opt to submit the results from just one phase III trial in Europe. But at this stage it is only considering this option

More From BioPortfolio on "Futura Medical mulling fast-track European submission for lead drug candidate"